Romano Steven J.

Dianthus Therapeutics, Inc. · Director

Romano Steven J. is listed in filings as Director at Dianthus Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 22, 2026, including 5 public disclosures. Recent filings connect the profile to Dianthus Therapeutics, Inc. (DNTH) and Silence Therapeutics plc (SLN). The current snapshot covers public activity from Sep 18, 2024 to May 22, 2026. Reported amounts are shown as $545.8K to $229.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.